$NOC

Key facts: NOC Q3 sales $11.1B; Guggenheim Keeps Buy

Northrop Grumman (NOC) reported Q3 sales of $11.1B, up 7% YoY, with EPS of $7.89. The company raised its 2026 EPS guidance to $29.35–$29.75 and expects 2027 sales growth of 5%–7%. Guggenheim maintained a Buy rating and $640 price target, citing strong performance.

Original reporting
Published Oct 22, 2026, 7:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 7:33 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Key facts: NOC Q3 sales $11.1B; Guggenheim Keeps Buy — source image
Decision brief

The 30-second read

$NOCBullishHigh
01

Why it matters

The raised EPS guidance and buy rating suggest a positive market reaction.

02

Market read

First report of Q3 results and upgraded guidance, likely to move the stock in early trading.

03

What to watch

Backlog size and award pipeline may not translate into near‑term revenue, limiting upside.

Relevance 8/10Novelty 8/10Timing: pre-market today

Background

Northrop Grumman's Q3 earnings and guidance release.

Company-level read

Ticker impact

$NOCBullishHigh confidence
Context

Northrop Grumman reported Q3 sales of $11.1B, EPS $7.89 and raised 2026 EPS guidance to $29.35‑$29.75.

Expected impact

upside pressure as investors price in higher EPS guidance

Evidence & confidence

The company increased its EPS guidance and received a buy rating with a $640 target, indicating confidence in future performance.

Market effects

Defense sector may see broader optimism from Northrop's raised guidance.

U.S. defense stocks could benefit in early trading.

Potential ripple to global aerospace and defense suppliers.

Counterpoint

If the guidance is overly optimistic, the stock could face disappointment if future quarters miss expectations.

Key entities

  • Northrop Grumman

    U.S. defense contractor

  • Guggenheim

    Maintained Buy rating with $640 price target

Related articles

$LMTHighAI 8/10

Lockheed Martin Rises 9% as Record Backlog Lifts Outlook; RTX Gains 2%, Northrop Grumman Advances 3%

Lockheed Martin (LMT) rose 9% after reporting Q3 results that beat estimates, with revenue up 11% to $20.7B, EPS at $7.97, and a record $292B backlog. The company raised its 2026 outlook, expecting revenue of $80B-$82B and EPS of $30.35-$30.75. RTX (RTX) and Northrop Grumman (NOC) also gained, up 2% and 3% respectively, as defense stocks outperformed the broader market.

$NOCMedAI 8/10

NOC's Q3 Earnings Call Highlights 2027 Growth and B-21 Spending

Northrop Grumman (NOC) reported Q3 2026 earnings, raising its 2026 profit outlook with segment operating income guidance increased by $65M. The company projected 5-7% sales growth for 2027, driven by Defense Systems and B-21 production. Quarterly earnings of $7.89 per share and revenues of $11.12B exceeded estimates. Management highlighted a record backlog of $109.6B but noted risks related to award timing and budget appropriations.

$RTXHighAI 8/10

Defense Earnings Week Opens With Three Raised Forecasts and Two Record Backlogs

RTX, Northrop Grumman, and GE Aerospace reported Q3 earnings, raising full-year guidance. RTX reported $25B sales, $2.26 adjusted EPS, and a $340B backlog. Northrop Grumman reported $11.1B sales, $7.89 EPS, and a $109.6B backlog. GE Aerospace reported $19B orders, $13.3B revenue, and $2.25 EPS. Lockheed Martin and L3Harris are set to report soon. NATO and U.S. defense spending commitments support sector growth.